Autonomix Medical (AMIX) Cash from Investing Activities (2023 - 2025)

Autonomix Medical (AMIX) has reported Cash from Investing Activities for 3 consecutive years, with -$7000.0 the latest figure, recorded in Q4 2025.

• On a quarterly basis, Cash from Investing Activities fell 40.0% year-over-year to -$7000.0 in Q4 2025; TTM through Dec 2025 was -$21000.0, a 27.59% increase from a year earlier, with the FY2024 full-year figure at -$19000.0, changed N/A from the prior year.
• Cash from Investing Activities was -$7000.0 for Q4 2025 at Autonomix Medical, up from -$14000.0 in the prior quarter.
• Over five years, Cash from Investing Activities peaked at -$5000.0 in Q2 2024 and troughed at -$19000.0 in Q1 2024.
• A 3-year average of -$11000.0 and a median of -$10500.0 in 2025 frame the typical range for Cash from Investing Activities.
• Across the five-year window, Cash from Investing Activities surged 68.75% in 2024 and tumbled 40.0% in 2025, its largest moves.
• Over 3 years, Cash from Investing Activities stood at -$16000.0 in 2023, then surged by 68.75% to -$5000.0 in 2024, then sank by 40.0% to -$7000.0 in 2025.
• The last three Cash from Investing Activities figures came in at -$7000.0 (Q4 2025), -$14000.0 (Q1 2025), and -$5000.0 (Q4 2024), per Business Quant data.